2022 ACC ECDP on the Role of Nonstatin Therapies for LDL-C Lowering in the Management of ASCVD Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee
J Am Coll Cardiol 2022 Aug 23;[EPub Ahead of Print], DM Lloyd-Jones, PB Morris, CM Ballantyne, KK Birtcher, AM Covington, SM DePalma, MB Minissian, CE Orringer, SC Smith, AA Waring, JT WilkinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.